By: Anton Bespalov
The EQIPD principles
June 16, 2021The EQIPD Toolbox now contains a set of principles, which may help scientists, stakeholders and users to better understand what the…
Read MoreEQIPD Quality System published
June 16, 2021The manuscript “Introduction to the EQIPD quality system” was recently accepted by and published in eLife. This publication marks an important milestone…
Read MoreThe Costs of Competitiveness
December 18, 2020In one of the recent Nature issues, there was a piece called “France’s reforms: the costs of competitiveness”. In a nutshell,…
Read MoreA time to cast away stones, and a time to gather stones together
December 18, 2020Since the seminal paper by Laura Bohn 20 years ago, expectations have built up that biased mu-opioid receptor agonists will deliver what we…
Read MoreIn vivo veritas
October 5, 2020Most of our readers are biologists but nevertheless we are occasionally exposed to medicinal chemistry literature describing novel research tools, lead…
Read MoreEstimation vs Hypothesis-Testing
November 22, 2019As some of our readers may know, the PAASP team was involved in the “Negative results Award” project that took place…
Read MoreARRIVE 2.0
November 22, 2019A long-awaited revision of the ARRIVE guidelines has finally been published (The ARRIVE guidelines 2019).What impact can we expect from ARRIVE…
Read MorePower analysis for two-sided t-test
December 20, 2018The example below does not require any additional R packages to be installed (i.e. runs with the basic R installation).This example…
Read More‘Don’t shoot the dog!’
February 27, 2018Behavioral scientists know very well how to train humans and animals to perform a desired response and how to avoid behaviors…
Read MoreWhat does the Net Present Value have to do with preclinical drug discovery research?
May 5, 2017When looking for Investors in the Life Science sector, entrepreneurial scientists and start-up companies have to deal with an unavoidable questions:…
Read More